The early data gave economists something to be upbeat about.
‘We are not entirely surprised we topped this list,’ Greg Foran admits.
Travel restrictions expected to ease mid-year as vaccine takes effect.
Business confidence is back to levels last seen in March 2018.
The full-year guidance has risen by several million dollars.
The shell of the finance minnow will look for a reverse takeover transaction.
Neal Barclay says Rio Tinto’s option to extend beyond late 2024 has now gone.
FDA first approved ESR's saliva testing six months ago.
But James Miller won't actually take up the role until August.
Vangelis Vitalis insists Apec is not just relevant but essential.
